SOPHiA GENETICS SA

SOPH55

Penny Stock

$3.75arrow_drop_down2.08%-$0.08

Penny Stock

SOPH55

$3.75

arrow_drop_down2.08%-$0.08

Penny Stock

Performance History

Key Stats
Open	$3.95
Prev. Close	$3.83
EPS	-1.02
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$253.57M
PE Ratio	-

	LOW	HIGH
Day Range	3.90	3.98
52 Week Range	2.32	7.37

Ratios







EPS	-1.02

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About SOPHiA GENETICS SA (SOPH)

SOPHiA GENETICS SA (SOPH) is a leading health tech company that focuses on democratizing Data-Driven Medicine. The company operates at the intersection of genomics and artificial intelligence (AI), providing healthcare professionals with innovative tools to enhance patient care. SOPHiA GENETICS SA was founded in 2011 and is headquartered in Switzerland. The company has been at the forefront of genomic analysis, leveraging advanced technologies and AI algorithms to interpret and analyze complex genetic data. With its unique combination of expertise in genomics and AI, SOPHiA GENETICS SA has positioned itself as a key player in the field of precision medicine.

SOPH stock has had an interesting price history since its initial public offering (IPO) in 2018. The stock initially experienced a surge in price, reflecting investor optimism about the company's potential in the growing genomics market. However, the stock price has since experienced some volatility, influenced by factors such as market conditions and investor sentiment. It is important to note that stock prices are subject to market fluctuations and may not always reflect the intrinsic value of the company.

Websitecall_made

Sector: Healthcare
Industry: Health Information Services
CEO: Dr. Jurgi Camblong M.B.A., Ph.D.
Headquarters: Saint-Sulpice
Employees: 466
Exchange: NASDAQ

Keep an eye on SOPHiA GENETICS SA

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is SOPHiA GENETICS SA's (SOPH) price per share?

The current price per share for SOPHiA GENETICS SA (SOPH) is $3.75. The stock has seen a price change of -$0.08 recently, indicating a -2.09% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for SOPHiA GENETICS SA (SOPH)?

For SOPHiA GENETICS SA (SOPH), the 52-week high is $7.37, which is 96.53% from the current price. The 52-week low is $2.32, the current price is 61.29% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is SOPHiA GENETICS SA (SOPH) a growth stock?

SOPHiA GENETICS SA (SOPH) has shown an average price growth of 0.41% over the past three years. It has received a score of 31 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying SOPHiA GENETICS SA as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is SOPHiA GENETICS SA (SOPH) stock price performance year to date (YTD)?

As of the latest data, SOPHiA GENETICS SA (SOPH) has a year-to-date price change of -22.36%. Over the past month, the stock has experienced a price change of 0.27%. Over the last three months, the change has been -18.66%. Over the past six months, the figure is -21.55%.

help

Is SOPHiA GENETICS SA (SOPH) a profitable company?

SOPHiA GENETICS SA (SOPH) has a net income of -$78.98M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 58.8% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -94.92% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $62.37M, with a revenue growth rate of 31.14%, providing insight into the company's sales performance and growth. The gross profit is $36.68M. Operating income is noted at -$76.91M. Furthermore, the EBITDA is -$68.01M.

help

What is the market capitalization of SOPHiA GENETICS SA (SOPH)?

SOPHiA GENETICS SA (SOPH) has a market capitalization of $253.58M. The average daily trading volume is 37.21K, indicating the stock's liquidity and investor engagement.